Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy

被引:55
作者
Ruzyllo, W
Chojnowska, L
Demkow, M
Witkowski, A
Kusmierczyk-Droszcz, B
Piotrowski, W
Rausinska, L
Karcz, M
Malecka, L
Rydlewska-Sadowska, W
机构
[1] Natl Inst Cardiol, Dept Gen Cardiol, PL-04628 Warsaw, Poland
[2] Natl Inst Cardiol, Catheterizat Lab, PL-04628 Warsaw, Poland
关键词
hypertrophic obstructive cardiomyopathy; catheter therapy; exercise capacity;
D O I
10.1053/euhj.1999.1905
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives This study was undertaken to evaluate midterm clinical results of non-surgical myocardial reduction in patients with hypertrophic obstructive cardiomyopathy. Methods Twenty-five patients with left ventricular outflow tract obstruction (mean gradient of 84.54 +/- 31.38 mmHg) and symptoms of dyspnoea, angina and/or syncope were treated with non-surgical myocardial reduction. The patients were followed-up for a mean period of 10.44 +/- 1.8 months. In all patients clinical examination with echocardiography was repeated after every 3 months of follow-up, and a symptom-limited treadmill test was repeated at the 6 month follow-up. Eighteen patients underwent simultaneous respiratory gas analysis. Results Clinical follow-up examinations were achieved in ail 25 patients. Persistent left ventricular outflow tract gradient reduction was seen in 23 patients. Seventeen patients had a reduction of left ventricular outflow tract gradient >50% of baseline value. Twenty patients showed a clinical improvement from 2.8 +/- 0.5 up to 1.2 +/- 0.5 NYHA class (P<0.001). The clinical improvement was matched by an improvement in objective measures of exercise capacity in patients with significant left ventricular outflow tract gradient reduction. Exercise time increased from 571.9 +/- 192.2 to 703.5 +/- 175.4 s, P<0.001, and peak VO2 increased from 14.6 +/- 5.2 to 20.5 +/- 8.6 ml . kg(-1) min(-1), P<0.05. Conclusion Significant left ventricular outflow tract gradient reduction with exercise capacity improvement was achieved in the majority of patients treated with nonsurgical myocardial reduction. We recommend this method as an alternative to surgery for symptomatic patients with hypertrophic obstructive cardiomyopathy. (C) 2000 The European Society of Cardiology.
引用
收藏
页码:770 / 777
页数:8
相关论文
共 22 条
[1]
MECHANISMS OF EXERCISE LIMITATION IN HYPERTROPHIC CARDIOMYOPATHY [J].
CHIKAMORI, T ;
COUNIHAN, PJ ;
DOI, YL ;
TAKATA, J ;
STEWART, JT ;
FRENNEAUX, MP ;
MCKENNA, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (03) :507-512
[2]
HYPERTROPHIC CARDIOMYOPATHY - DISAPPEARANCE OF AUSCULTATORY, CAROTID PULSE, AND ECHOCARDIOGRAPHIC MANIFESTATIONS OF OBSTRUCTION FOLLOWING MYOCARDIAL-INFARCTION [J].
COME, PC ;
RILEY, MF .
CHEST, 1982, 82 (04) :451-454
[3]
Gietzen F., 1994, European Heart Journal, V15, P125
[4]
Gietzen F., 1997, European Heart Journal, V18, P468
[5]
TRANSESOPHAGEAL DOPPLER ECHOCARDIOGRAPHY IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - CLARIFICATION OF PATHOPHYSIOLOGY AND IMPORTANCE IN INTRAOPERATIVE DECISION-MAKING [J].
GRIGG, LE ;
WIGLE, ED ;
WILLIAMS, WG ;
DANIEL, LB ;
RAKOWSKI, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (01) :42-52
[6]
MECHANISM OF LEFT-VENTRICULAR OUTFLOW OBSTRUCTION IN PATIENTS WITH OBSTRUCTIVE ASYMMETRIC SEPTAL HYPERTROPHY (IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS) [J].
HENRY, WL ;
CLARK, CE ;
GRIFFITH, JM ;
EPSTEIN, SE .
AMERICAN JOURNAL OF CARDIOLOGY, 1975, 35 (03) :337-345
[7]
Kappenberger L, 1997, EUR HEART J, V18, P1249
[8]
Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy [J].
Kazmierczak, J ;
Kornacewicz-Jach, Z ;
Kisly, M ;
Gil, R ;
Wojtarowicz, A .
HEART, 1998, 80 (03) :257-262
[9]
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Outcome in the first series of patients [J].
Knight, C ;
Kurbaan, AS ;
Seggewiss, H ;
Henein, M ;
Gunning, M ;
Harrington, D ;
Fassbender, D ;
Gleichmann, U ;
Sigwart, U .
CIRCULATION, 1997, 95 (08) :2075-2081
[10]
HYPERTROPHIC CARDIOMYOPATHY - INTERRELATIONS OF CLINICAL MANIFESTATIONS, PATHOPHYSIOLOGY, AND THERAPY .1. [J].
MARON, BJ ;
BONOW, RO ;
CANNON, RO ;
LEON, MB ;
EPSTEIN, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) :780-789